Chemed Corporation (NYSE: CHE) Stock Competitors & Peer Comparison
See CHE's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CHE and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHE | $511.13 | +1.61% | 6.8B | 23.66 | $21.61 | +0.47% |
| HCA | $382.19 | +1.51% | 84.8B | 13.20 | $28.96 | +0.78% |
| THC | $233.20 | +17.17% | 20.1B | 13.53 | $17.24 | N/A |
| DVA | $235.44 | +0.50% | 15.1B | 20.06 | $11.73 | N/A |
| SOLV | $78.01 | +1.00% | 13.5B | 12.50 | $6.24 | N/A |
| FMS | $24.59 | +0.61% | 13.2B | 9.76 | $2.52 | +3.52% |
| EHC | $112.89 | +1.65% | 11.2B | 19.83 | $5.69 | +0.67% |
| ENSG | $172.99 | +3.27% | 10.1B | 25.07 | $6.90 | +0.15% |
| UHS | $155.75 | +2.96% | 9.8B | 6.91 | $22.54 | +0.51% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
CHE vs HCA Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, HCA has a market cap of 84.8B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while HCA trades at $382.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas HCA's P/E ratio is 13.20. In terms of profitability, CHE's ROE is +0.25%, compared to HCA's ROE of -1.54%. Regarding short-term risk, CHE is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for CHE.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
CHE vs THC Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, THC has a market cap of 20.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while THC trades at $233.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas THC's P/E ratio is 13.53. In terms of profitability, CHE's ROE is +0.25%, compared to THC's ROE of +0.38%. Regarding short-term risk, CHE is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for CHE.Check THC's competition here
DaVita Inc. (NYSE: DVA)
CHE vs DVA Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, DVA has a market cap of 15.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while DVA trades at $235.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas DVA's P/E ratio is 20.06. In terms of profitability, CHE's ROE is +0.25%, compared to DVA's ROE of -1.33%. Regarding short-term risk, CHE is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for CHE.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
CHE vs SOLV Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, SOLV has a market cap of 13.5B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while SOLV trades at $78.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas SOLV's P/E ratio is 12.50. In terms of profitability, CHE's ROE is +0.25%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, CHE is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for CHE.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
CHE vs FMS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, FMS has a market cap of 13.2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while FMS trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas FMS's P/E ratio is 9.76. In terms of profitability, CHE's ROE is +0.25%, compared to FMS's ROE of +0.07%. Regarding short-term risk, CHE is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for CHE.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
CHE vs EHC Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, EHC has a market cap of 11.2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while EHC trades at $112.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas EHC's P/E ratio is 19.83. In terms of profitability, CHE's ROE is +0.25%, compared to EHC's ROE of +0.25%. Regarding short-term risk, CHE is less volatile compared to EHC. This indicates lower risk in terms of short-term price fluctuations for CHE.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
CHE vs ENSG Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while ENSG trades at $172.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas ENSG's P/E ratio is 25.07. In terms of profitability, CHE's ROE is +0.25%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, CHE is less volatile compared to ENSG. This indicates lower risk in terms of short-term price fluctuations for CHE.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
CHE vs UHS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, UHS has a market cap of 9.8B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while UHS trades at $155.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas UHS's P/E ratio is 6.91. In terms of profitability, CHE's ROE is +0.25%, compared to UHS's ROE of +0.21%. Regarding short-term risk, CHE is less volatile compared to UHS. This indicates lower risk in terms of short-term price fluctuations for CHE.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
CHE vs OSH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas OSH's P/E ratio is -17.65. In terms of profitability, CHE's ROE is +0.25%, compared to OSH's ROE of +4.64%. Regarding short-term risk, CHE is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for CHE.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
CHE vs PACS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while PACS trades at $46.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas PACS's P/E ratio is 39.80. In terms of profitability, CHE's ROE is +0.25%, compared to PACS's ROE of +0.27%. Regarding short-term risk, CHE is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for CHE.Check PACS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
CHE vs LHCG Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas LHCG's P/E ratio is 82.83. In terms of profitability, CHE's ROE is +0.25%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, CHE is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for CHE.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
CHE vs LFST Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while LFST trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas LFST's P/E ratio is 173.65. In terms of profitability, CHE's ROE is +0.25%, compared to LFST's ROE of +0.02%. Regarding short-term risk, CHE is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for CHE.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
CHE vs CON Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CON has a market cap of 4B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CON's P/E ratio is 21.95. In terms of profitability, CHE's ROE is +0.25%, compared to CON's ROE of +0.46%. Regarding short-term risk, CHE is less volatile compared to CON. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CON's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
CHE vs BKD Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, BKD has a market cap of 3.6B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while BKD trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas BKD's P/E ratio is -26.11. In terms of profitability, CHE's ROE is +0.25%, compared to BKD's ROE of +401.19%. Regarding short-term risk, CHE is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for CHE.Check BKD's competition here
National HealthCare Corporation (AMEX: NHC)
CHE vs NHC Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while NHC trades at $225.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas NHC's P/E ratio is 32.32. In terms of profitability, CHE's ROE is +0.25%, compared to NHC's ROE of +0.12%. Regarding short-term risk, CHE is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for CHE.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
CHE vs OPCH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, OPCH has a market cap of 3.4B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while OPCH trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas OPCH's P/E ratio is 12.59. In terms of profitability, CHE's ROE is +0.25%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, CHE is less volatile compared to OPCH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
CHE vs AMED Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AMED's P/E ratio is 39.30. In terms of profitability, CHE's ROE is +0.25%, compared to AMED's ROE of +0.11%. Regarding short-term risk, CHE is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for CHE.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
CHE vs ACHC Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, ACHC has a market cap of 3.2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while ACHC trades at $34.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas ACHC's P/E ratio is 17.34. In terms of profitability, CHE's ROE is +0.25%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, CHE is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for CHE.Check ACHC's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
CHE vs MD Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while MD trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas MD's P/E ratio is 12.27. In terms of profitability, CHE's ROE is +0.25%, compared to MD's ROE of +0.20%. Regarding short-term risk, CHE is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for CHE.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
CHE vs ADUS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while ADUS trades at $114.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas ADUS's P/E ratio is 17.79. In terms of profitability, CHE's ROE is +0.25%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, CHE is less volatile compared to ADUS. This indicates lower risk in terms of short-term price fluctuations for CHE.Check ADUS's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
CHE vs AVAH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AVAH trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AVAH's P/E ratio is 13.90. In terms of profitability, CHE's ROE is +0.25%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, CHE is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AVAH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
CHE vs SGRY Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while SGRY trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas SGRY's P/E ratio is 40.33. In terms of profitability, CHE's ROE is +0.25%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, CHE is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for CHE.Check SGRY's competition here
Select Medical Holdings Corporation (NYSE: SEM)
CHE vs SEM Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas SEM's P/E ratio is 15.43. In terms of profitability, CHE's ROE is +0.25%, compared to SEM's ROE of +0.08%. Regarding short-term risk, CHE is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for CHE.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
CHE vs ASTH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while ASTH trades at $40.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas ASTH's P/E ratio is 27.24. In terms of profitability, CHE's ROE is +0.25%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, CHE is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
CHE vs AMEH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AMEH's P/E ratio is 39.25. In terms of profitability, CHE's ROE is +0.25%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, CHE is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
CHE vs AGL Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AGL trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AGL's P/E ratio is -9.57. In terms of profitability, CHE's ROE is +0.25%, compared to AGL's ROE of -1.46%. Regarding short-term risk, CHE is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
CHE vs INNV Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while INNV trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas INNV's P/E ratio is -128.44. In terms of profitability, CHE's ROE is +0.25%, compared to INNV's ROE of -0.09%. Regarding short-term risk, CHE is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for CHE.Check INNV's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
CHE vs HCSG Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while HCSG trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas HCSG's P/E ratio is 18.19. In terms of profitability, CHE's ROE is +0.25%, compared to HCSG's ROE of +0.23%. Regarding short-term risk, CHE is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for CHE.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
CHE vs ARDT Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while ARDT trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas ARDT's P/E ratio is 6.47. In terms of profitability, CHE's ROE is +0.25%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, CHE is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for CHE.Check ARDT's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
CHE vs PNTG Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while PNTG trades at $41.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas PNTG's P/E ratio is 33.46. In terms of profitability, CHE's ROE is +0.25%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, CHE is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for CHE.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
CHE vs AMN Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AMN trades at $32.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AMN's P/E ratio is 10.93. In terms of profitability, CHE's ROE is +0.25%, compared to AMN's ROE of -0.05%. Regarding short-term risk, CHE is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
CHE vs BKDT Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas BKDT's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, CHE is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for CHE.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
CHE vs USPH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while USPH trades at $74.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas USPH's P/E ratio is 28.74. In terms of profitability, CHE's ROE is +0.25%, compared to USPH's ROE of +0.00%. Regarding short-term risk, CHE is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check USPH's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
CHE vs CMPS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CMPS has a market cap of 1.1B. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CMPS trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CMPS's P/E ratio is -5.49. In terms of profitability, CHE's ROE is +0.25%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, CHE is less volatile compared to CMPS. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CMPS's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
CHE vs FSHCX Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, FSHCX has a market cap of 882M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while FSHCX trades at $120.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas FSHCX's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to FSHCX's ROE of N/A. Regarding short-term risk, CHE is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for CHE.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALKW)
CHE vs TALKW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, TALKW has a market cap of 874.4M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas TALKW's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, CHE is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for CHE.Check TALKW's competition here
Talkspace, Inc. (NASDAQ: TALK)
CHE vs TALK Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, TALK has a market cap of 872.7M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while TALK trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas TALK's P/E ratio is 768.44. In terms of profitability, CHE's ROE is +0.25%, compared to TALK's ROE of +0.01%. Regarding short-term risk, CHE is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for CHE.Check TALK's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
CHE vs NUTX Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, NUTX has a market cap of 868.6M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while NUTX trades at $145.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas NUTX's P/E ratio is 11.27. In terms of profitability, CHE's ROE is +0.25%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, CHE is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for CHE.Check NUTX's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
CHE vs SNDA Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, SNDA has a market cap of 833.8M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while SNDA trades at $41.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas SNDA's P/E ratio is -7.72. In terms of profitability, CHE's ROE is +0.25%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, CHE is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for CHE.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
CHE vs EHAB Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas EHAB's P/E ratio is -197.14. In terms of profitability, CHE's ROE is +0.25%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, CHE is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for CHE.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
CHE vs GMRS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, GMRS has a market cap of 594M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while GMRS trades at $12.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas GMRS's P/E ratio is 5.76. In terms of profitability, CHE's ROE is +0.25%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, CHE is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for CHE.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
CHE vs TOI Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, TOI has a market cap of 497.9M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while TOI trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas TOI's P/E ratio is -13.83. In terms of profitability, CHE's ROE is +0.25%, compared to TOI's ROE of +3.27%. Regarding short-term risk, CHE is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for CHE.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
CHE vs VMD Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, VMD has a market cap of 451.2M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while VMD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas VMD's P/E ratio is 31.81. In terms of profitability, CHE's ROE is +0.25%, compared to VMD's ROE of +0.11%. Regarding short-term risk, CHE is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for CHE.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
CHE vs MCTA Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas MCTA's P/E ratio is 419.36. In terms of profitability, CHE's ROE is +0.25%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, CHE is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for CHE.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
CHE vs SRTA Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, SRTA has a market cap of 436.1M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while SRTA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas SRTA's P/E ratio is -35.46. In terms of profitability, CHE's ROE is +0.25%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, CHE is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for CHE.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
CHE vs TOIIW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, TOIIW has a market cap of 388.9M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, CHE's ROE is +0.25%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, CHE is less volatile compared to TOIIW. This indicates lower risk in terms of short-term price fluctuations for CHE.Check TOIIW's competition here
Community Health Systems, Inc. (NYSE: CYH)
CHE vs CYH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CYH has a market cap of 384M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CYH trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CYH's P/E ratio is 3.73. In terms of profitability, CHE's ROE is +0.25%, compared to CYH's ROE of +0.21%. Regarding short-term risk, CHE is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
CHE vs AUNA Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AUNA has a market cap of 373.8M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AUNA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AUNA's P/E ratio is 4.55. In terms of profitability, CHE's ROE is +0.25%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, CHE is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AUNA's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
CHE vs AIRS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AIRS has a market cap of 325.2M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AIRS trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AIRS's P/E ratio is -153.67. In terms of profitability, CHE's ROE is +0.25%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, CHE is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
CHE vs CSU Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CSU's P/E ratio is 0.67. In terms of profitability, CHE's ROE is +0.25%, compared to CSU's ROE of -0.51%. Regarding short-term risk, CHE is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
CHE vs JYNT Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, JYNT has a market cap of 119M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while JYNT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas JYNT's P/E ratio is 83.50. In terms of profitability, CHE's ROE is +0.25%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, CHE is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for CHE.Check JYNT's competition here
biote Corp. (NASDAQ: BTMD)
CHE vs BTMD Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, BTMD has a market cap of 100.6M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while BTMD trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas BTMD's P/E ratio is 5.18. In terms of profitability, CHE's ROE is +0.25%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, CHE is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for CHE.Check BTMD's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
CHE vs FVE Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas FVE's P/E ratio is -5.64. In terms of profitability, CHE's ROE is +0.25%, compared to FVE's ROE of -0.15%. Regarding short-term risk, CHE is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for CHE.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
CHE vs KDLYW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas KDLYW's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, CHE is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for CHE.Check KDLYW's competition here
DocGo Inc. (NASDAQ: DCGO)
CHE vs DCGO Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, DCGO has a market cap of 58.9M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while DCGO trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas DCGO's P/E ratio is -0.68. In terms of profitability, CHE's ROE is +0.25%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, CHE is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for CHE.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
CHE vs ALR Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas ALR's P/E ratio is -1.11. In terms of profitability, CHE's ROE is +0.25%, compared to ALR's ROE of -0.15%. Regarding short-term risk, CHE is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for CHE.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
CHE vs PARK Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, PARK has a market cap of 36.5M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while PARK trades at $18.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas PARK's P/E ratio is 25.36. In terms of profitability, CHE's ROE is +0.25%, compared to PARK's ROE of -0.24%. Regarding short-term risk, CHE is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for CHE.Check PARK's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
CHE vs IMAC Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas IMAC's P/E ratio is -2.27. In terms of profitability, CHE's ROE is +0.25%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, CHE is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for CHE.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
CHE vs PIII Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, PIII has a market cap of 31.5M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while PIII trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas PIII's P/E ratio is -0.24. In terms of profitability, CHE's ROE is +0.25%, compared to PIII's ROE of +1.85%. Regarding short-term risk, CHE is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for CHE.Check PIII's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
CHE vs CCEL Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CCEL has a market cap of 28.1M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CCEL trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CCEL's P/E ratio is -10.55. In terms of profitability, CHE's ROE is +0.25%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, CHE is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
CHE vs CANO-WT Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, CHE is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
CHE vs AIH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AIH's P/E ratio is -2.78. In terms of profitability, CHE's ROE is +0.25%, compared to AIH's ROE of +1.16%. Regarding short-term risk, CHE is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
CHE vs CANO Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CANO's P/E ratio is -0.01. In terms of profitability, CHE's ROE is +0.25%, compared to CANO's ROE of -1.49%. Regarding short-term risk, CHE is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
CHE vs FPCG Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas FPCG's P/E ratio is 0.09. In terms of profitability, CHE's ROE is +0.25%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, CHE is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for CHE.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
CHE vs FTRP Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas FTRP's P/E ratio is -1.22. In terms of profitability, CHE's ROE is +0.25%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, CHE is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for CHE.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
CHE vs AMS Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AMS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AMS's P/E ratio is -6.47. In terms of profitability, CHE's ROE is +0.25%, compared to AMS's ROE of -0.06%. Regarding short-term risk, CHE is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
CHE vs BMGL Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, BMGL has a market cap of 9.2M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while BMGL trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas BMGL's P/E ratio is -1.11. In terms of profitability, CHE's ROE is +0.25%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, CHE is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for CHE.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
CHE vs XWEL Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, XWEL has a market cap of 6.4M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while XWEL trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas XWEL's P/E ratio is -0.32. In terms of profitability, CHE's ROE is +0.25%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, CHE is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for CHE.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
CHE vs MODV Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas MODV's P/E ratio is -0.06. In terms of profitability, CHE's ROE is +0.25%, compared to MODV's ROE of +1.36%. Regarding short-term risk, CHE is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for CHE.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
CHE vs GBNH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas GBNH's P/E ratio is -0.06. In terms of profitability, CHE's ROE is +0.25%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, CHE is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for CHE.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
CHE vs RHE-PA Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, CHE's ROE is +0.25%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, CHE is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for CHE.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
CHE vs RHE Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas RHE's P/E ratio is -1.79. In terms of profitability, CHE's ROE is +0.25%, compared to RHE's ROE of -0.36%. Regarding short-term risk, CHE is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for CHE.Check RHE's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
CHE vs AIDX Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AIDX has a market cap of 2.8M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AIDX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AIDX's P/E ratio is -0.93. In terms of profitability, CHE's ROE is +0.25%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, CHE is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
CHE vs IMACW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas IMACW's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, CHE is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for CHE.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
CHE vs NAKAW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, CHE's ROE is +0.25%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, CHE is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for CHE.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
CHE vs CCM Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, CCM has a market cap of 626.1K. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while CCM trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas CCM's P/E ratio is -0.29. In terms of profitability, CHE's ROE is +0.25%, compared to CCM's ROE of +0.06%. Regarding short-term risk, CHE is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for CHE.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
CHE vs NIVF Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, NIVF has a market cap of 212.3K. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while NIVF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas NIVF's P/E ratio is 0.55. In terms of profitability, CHE's ROE is +0.25%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, CHE is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for CHE.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
CHE vs MNDR Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, MNDR has a market cap of 53.6K. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while MNDR trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas MNDR's P/E ratio is -0.05. In terms of profitability, CHE's ROE is +0.25%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, CHE is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for CHE.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
CHE vs NIVFW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, NIVFW has a market cap of 50K. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, CHE's ROE is +0.25%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, CHE is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for CHE.Check NIVFW's competition here
DocGo Inc. (NASDAQ: DCGOW)
CHE vs DCGOW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas DCGOW's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, CHE is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for CHE.Check DCGOW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
CHE vs TLMDW Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas TLMDW's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, CHE is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for CHE.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
CHE vs HNGR Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas HNGR's P/E ratio is 19.71. In terms of profitability, CHE's ROE is +0.25%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, CHE is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for CHE.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
CHE vs ATIP-WT Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, CHE is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for CHE.Check ATIP-WT's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
CHE vs TVTY Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas TVTY's P/E ratio is 19.06. In terms of profitability, CHE's ROE is +0.25%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, CHE is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for CHE.Check TVTY's competition here
New Frontier Health Corporation (NYSE: NFH)
CHE vs NFH Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, NFH has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas NFH's P/E ratio is -19.75. In terms of profitability, CHE's ROE is +0.25%, compared to NFH's ROE of -0.06%. Regarding short-term risk, CHE is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for CHE.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
CHE vs SLHGP Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, CHE's ROE is +0.25%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, CHE is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for CHE.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
CHE vs SLHG Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas SLHG's P/E ratio is -1.48. In terms of profitability, CHE's ROE is +0.25%, compared to SLHG's ROE of N/A. Regarding short-term risk, CHE is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for CHE.Check SLHG's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
CHE vs DVCR Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas DVCR's P/E ratio is 28.34. In terms of profitability, CHE's ROE is +0.25%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, CHE is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for CHE.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
CHE vs AFAM Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas AFAM's P/E ratio is N/A. In terms of profitability, CHE's ROE is +0.25%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, CHE is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for CHE.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
CHE vs TLMD Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas TLMD's P/E ratio is -1.60. In terms of profitability, CHE's ROE is +0.25%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, CHE is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for CHE.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
CHE vs KND Comparison July 2026
Chemed Corporation (NYSE: CHE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHE stands at 6.8B. In comparison, KND has a market cap of 0. Regarding current trading prices, CHE is priced at $511.13 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHE currently has a P/E ratio of 23.66, whereas KND's P/E ratio is -1.14. In terms of profitability, CHE's ROE is +0.25%, compared to KND's ROE of -0.53%. Regarding short-term risk, CHE is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for CHE.Check KND's competition here